Iambic Therapeutics
Iambic is seeking a Director, IP Counsel to lead its intellectual property function, reporting to the General Counsel. This role involves building and executing a global IP strategy to protect the company's small molecule pipeline and AI-driven discovery platform. The ideal candidate will be a hands-on attorney capable of drafting and prosecuting patent applications, conducting IP analyses, and managing outside counsel while leveraging AI tools for efficiency.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2020
Iambic Therapeutics is a biotech company applying an AI-driven platform — including its Enchant and NeuralPLexer technologies — to tackle the most challenging design problems in drug discovery and address unmet patient needs. Its high-throughput experimental platform converts novel molecular designs into biological insights, enabling faster development of potential best-in-class and first-in-class medicines. Iambic maintains a proprietary clinical pipeline targeting cancers such as HER2-driven tumors and breast cancer, and pursues collaborations with pharmaceutical partners, including Bayer, to advance AI-driven drug discovery.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Iambic Therapeutics.